Adnkronos After an initial information campaign on the importance of genomic testing for breast cancer, aimed at Europa Donna member associations, we worked alongside clinicians and scientific societies to reach the €20 million fund goal. We then monitored the regions most in difficulty, those unable to utilize the resources, finding that the reasons were often bureaucratic.
In our opinion, it is essential to include these tests in the Essential Levels of Assistance (LEA), so that there is no longer any need to debate the remaining availability of funds and all women can access the test much more easily." This was explained by Rosanna D'Antona, president of Europa Donna Italia, participating in the press conference "Breast cancer, the first two years of activity of the National Observatory on genomic testing," held today in Milan.
https://www.youtube.com/watch?v=v9VLrP0-pzg